\n\t\t\t\t\t\t\t\t\t\t\t\t\t
Area covered<\/h3>\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t
PHT supports companies in two sectors in particular:<\/p>\n
\n- Start-ups developing diagnostic or analysis platforms (neurological diagnostics, cytometric analyses, for example) combining excellent mastery of Big Data and artificial intelligence with proven medical advances, leading to early sales.<\/li>\n
- Biotechnology or biomedical start-ups developing a response to serious diseases for which there is no available treatment, based on breakthrough innovations that offer a real therapeutic innovation and have demonstrated their effectiveness in animal models.<\/li>\n<\/ul>\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t \t\t \t<\/div>\n\t <\/div>\n\t<\/div>\n\n\n\n
\n\n\n\n\n\n\t\n\t
\n\t \t
\n\t \t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
These start-ups are generally positioned between two phases of development and valuation:<\/p>\n